116 related articles for article (PubMed ID: 36929215)
21. Down-regulation of sphingosine kinase 2 (SphK2) increases the effects of all-trans-retinoic acid (ATRA) on colon cancer cells.
Chu JH; Gao ZH; Qu XJ
Biomed Pharmacother; 2014 Oct; 68(8):1089-97. PubMed ID: 25455157
[TBL] [Abstract][Full Text] [Related]
22. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.
Ling X; Bernacki RJ; Brattain MG; Li F
J Biol Chem; 2004 Apr; 279(15):15196-203. PubMed ID: 14722122
[TBL] [Abstract][Full Text] [Related]
23. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
Liu H; Tekle C; Chen YW; Kristian A; Zhao Y; Zhou M; Liu Z; Ding Y; Wang B; Mælandsmo GM; Nesland JM; Fodstad O; Tan M
Mol Cancer Ther; 2011 Jun; 10(6):960-71. PubMed ID: 21518725
[TBL] [Abstract][Full Text] [Related]
24. [Silencing RRM1 gene reverses paclitaxel resistance in human breast cancer cell line MCF- 7/R by inducing cell apoptosis].
Tian N; Zhou L; Yang D; Wu H; Ma Y; Lü L; Wu S
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):304-312. PubMed ID: 31068300
[TBL] [Abstract][Full Text] [Related]
25. The Role of Sphingomyelin Metabolism in the Protection of Rat Brain Microvascular Endothelial Cells by Mild Hypothermia.
Zhang HH; Wang L; Zhang W; Wan Z
Neurocrit Care; 2022 Apr; 36(2):546-559. PubMed ID: 34508278
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
28. Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer.
Xu R; Nakano K; Iwasaki H; Kumagai M; Wakabayashi R; Yamasaki A; Suzuki H; Mibu R; Onishi H; Katano M
Cancer Lett; 2011 Jul; 306(2):151-60. PubMed ID: 21429662
[TBL] [Abstract][Full Text] [Related]
29. Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation-induced cell apoptosis via sphingosine kinase 2 and FAK/AKT pathway.
Zhang R; Li L; Yuan L; Zhao M
Exp Mol Pathol; 2016 Feb; 100(1):51-8. PubMed ID: 26621495
[TBL] [Abstract][Full Text] [Related]
30. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
Zhu HW; Jiang D; Xie ZY; Zhou MH; Sun DY; Zhao YG
Genet Mol Res; 2015 Dec; 14(4):18695-702. PubMed ID: 26782519
[TBL] [Abstract][Full Text] [Related]
31. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of survivin enhances paclitaxel-induced Hela cell apoptosis.
Gu F; Li L; Yuan QF; Li C; Li ZH
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3504-3509. PubMed ID: 28829489
[TBL] [Abstract][Full Text] [Related]
33. [Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
Yan XJ; Liang LZ; Zeng ZY; Fu LW; Shi Z
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):609-13. PubMed ID: 16202317
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
[TBL] [Abstract][Full Text] [Related]
35. The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel.
Hou W; Guan J; Lu H; Dong Q; Han Y; Zhang R
J Ovarian Res; 2014 Sep; 7():89. PubMed ID: 25297825
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel.
Huang Z; Gao Y; Hou D
Hum Cell; 2020 Jul; 33(3):850-858. PubMed ID: 32452013
[TBL] [Abstract][Full Text] [Related]
37. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
[TBL] [Abstract][Full Text] [Related]
38. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells.
Dong H; Yao L; Bi W; Wang F; Song W; Lv Y
J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.
Wang S; Huang J; Lyu H; Cai B; Yang X; Li F; Tan J; Edgerton SM; Thor AD; Lee CK; Liu B
Breast Cancer Res; 2013; 15(5):R101. PubMed ID: 24168763
[TBL] [Abstract][Full Text] [Related]
40. [Suppression of survivin gene in leukemia cells by small interfering RNA].
Wang TY; Feng SQ; Zhang ZX; Shi XD; Liu R; Liu ZQ
Zhonghua Er Ke Za Zhi; 2010 Nov; 48(11):843-7. PubMed ID: 21215029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
